Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 150

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 150
---
 LLC (“OrbiMed Capital”) is the investment advisor of each of BIOG and OPM. As a result, OrbiMed Capital has              
 the power to direct the vote and disposition of the Common Shares held by BIOG and OPM and may be deemed directly or indirectly, including by reason of mutual affiliation, to be the beneficial owner of the Common Shares held by BIOG and OPM. OrbiMed 
 Capital exercises this investment and voting power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the Common Shares held by BIOG and OPM. Dr. Bonita      
 is a member of OrbiMed Capital. The address of each of the above persons and entities is 601 Lexington Avenue, 54th Floor, New York, NY 10022.                                                                                                            |

| (5) | Consists of (a) 25,276 Common Shares held by Mr. Forte and (b) 657,972 Common Shares issuable upon                                        
 the exercise of options granted to Mr. Forte that are currently exercisable or will become exercisable within 60 days of the Record Date. |

| (6) | Consists of (a) 48,781 Common Shares held by Dr. Zinda and (b) 564,253 Common Shares issuable upon the                                
 exercise of options granted to Dr. Zinda that are currently exercisable or will become exercisable within 60 days of the Record Date. |

| (7) | Consists of (i) 12,822 Common Shares held by Ms. Alves and (ii) 138,063 Common Shares issuable upon the                               
 exercise of options granted to Ms. Alves that are currently exercisable or will become exercisable within 60 days of the Record Date. |

| (8) | Consists of (a) 3,177,041 Common Shares held by OrbiMed Private Investments VII, L.P. (“OPI VII”),                                                                                                                                      
 (b) 49,257 Common Shares held by The Biotech Growth Trust PLC (“BIOG”), (c) 96,190 Common Shares held by OrbiMed Partners Master Fund Limited (“OPM”) and (d) with respect to David Bonita, M.D., a member of our board of              
 directors, only, 124,400 Common Shares issuable upon the exercise of options granted to Dr. Bonita that are exerc